Literature DB >> 17018521

The role of hypothalamic malonyl-CoA in energy homeostasis.

Michael J Wolfgang1, M Daniel Lane.   

Abstract

Energy balance is monitored by hypothalamic neurons that respond to peripheral hormonal and afferent neural signals that sense energy status. Recent physiologic, pharmacologic, and genetic evidence has implicated malonyl-CoA, an intermediate in fatty acid synthesis, as a regulatory component of this energy-sensing system. The level of malonyl-CoA in the hypothalamus is dynamically regulated by fasting and feeding, which alter subsequent feeding behavior. Fatty acid synthase (FAS) inhibitors, administered systemically or intracerebroventricularly to lean or obese mice, increase hypothalamic malonyl-CoA leading to the suppression of food intake. Conversely, lowering malonyl-CoA with an acetyl-CoA carboxylase (ACC) inhibitor or by the ectopic expression of malonyl-CoA decarboxylase in the hypothalamus increases food intake and reverses inhibition by FAS inhibitors. Physiologically, the level of hypothalamic malonyl-CoA appears to be determined through phosphorylation/dephosphorylation of ACC by AMP kinase in response to changes in the AMP/ATP ratio, an indicator of energy status. Recent evidence suggests that the brain-specific carnitine:palmitoyl-CoA transferase-1 (CPT1c) may be a regulated target of malonyl-CoA that relays the "malonyl-CoA signal" in hypothalamic neurons that express the orexigenic and anorexigenic neuropeptides that regulate food intake and peripheral energy expenditure. Together these findings support a role for malonyl-CoA as an intermediary in the control of energy homeostasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17018521     DOI: 10.1074/jbc.R600016200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

Review 1.  Hypothalamic malonyl-coenzyme A and the control of energy balance.

Authors:  Michael J Wolfgang; M Daniel Lane
Journal:  Mol Endocrinol       Date:  2008-03-20

Review 2.  Targeting the CNS to treat type 2 diabetes.

Authors:  Darleen A Sandoval; Silvana Obici; Randy J Seeley
Journal:  Nat Rev Drug Discov       Date:  2009-05       Impact factor: 84.694

3.  Differential effects of central fructose and glucose on hypothalamic malonyl-CoA and food intake.

Authors:  Seung Hun Cha; Michael Wolfgang; Yuka Tokutake; Shigeru Chohnan; M Daniel Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-29       Impact factor: 11.205

4.  The Carnitine Palmitoyl Transferase (CPT) System and Possible Relevance for Neuropsychiatric and Neurological Conditions.

Authors:  Ashraf Virmani; Luigi Pinto; Otto Bauermann; Saf Zerelli; Andreas Diedenhofen; Zbigniew K Binienda; Syed F Ali; Feike R van der Leij
Journal:  Mol Neurobiol       Date:  2015-06-04       Impact factor: 5.590

5.  Targeted chemical-genetic regulation of protein stability in vivo.

Authors:  Susana Rodriguez; Michael J Wolfgang
Journal:  Chem Biol       Date:  2012-03-23

6.  A ketone ester diet increases brain malonyl-CoA and Uncoupling proteins 4 and 5 while decreasing food intake in the normal Wistar Rat.

Authors:  Yoshihiro Kashiwaya; Robert Pawlosky; William Markis; M Todd King; Christian Bergman; Shireesh Srivastava; Andrew Murray; Kieran Clarke; Richard L Veech
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

7.  The Mammalian Malonyl-CoA Synthetase ACSF3 Is Required for Mitochondrial Protein Malonylation and Metabolic Efficiency.

Authors:  Caitlyn E Bowman; Susana Rodriguez; Ebru S Selen Alpergin; Michelle G Acoba; Liang Zhao; Thomas Hartung; Steven M Claypool; Paul A Watkins; Michael J Wolfgang
Journal:  Cell Chem Biol       Date:  2017-05-04       Impact factor: 8.116

8.  Pantothenate kinase 1 is required to support the metabolic transition from the fed to the fasted state.

Authors:  Roberta Leonardi; Jerold E Rehg; Charles O Rock; Suzanne Jackowski
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

9.  Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide.

Authors:  Soona Shin; Junko Wakabayashi; Melinda S Yates; Nobunao Wakabayashi; Patrick M Dolan; Susan Aja; Karen T Liby; Michael B Sporn; Masayuki Yamamoto; Thomas W Kensler
Journal:  Eur J Pharmacol       Date:  2009-08-19       Impact factor: 4.432

Review 10.  Molecular physiology of mammalian glucokinase.

Authors:  P B Iynedjian
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.